Paper39690296
Isolation, Structure, and Biological Activities of Exopolysaccharides from Actinomycetes: A Review.
Wei XL and 3 others. Curr Microbiol, 2024. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation, Structure, and Biological Activities of Exopolysaccharides from Actinomycetes: A Review. Papers, record 39690296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39690296
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation, Structure, and Biological Activities of Exopolysaccharides from Actinomycetes: A Review.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Actinobacteria | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Humans | |
| Antineoplastic Agents | |
| Antiviral Agents | |
| Immunologic Factors | |
| Animals |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AD22035111 | Guangxi Science and Technology Base and Talent Special Programme | PubMed | ||
| yy2021sk001 | Exploring the diversity and metabolic potential of medicinal plant endophyte resources | PubMed | ||
| 20224136 | Baise City regional multi-incidence joint special plan program | PubMed | ||
| 20224138 | Baise City regional multi-incidence joint special plan program | PubMed | ||
| DC2200001901 | Financial Special Guangxi First-class Discipline Construction Fund- Young Academic Backbone program | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,887,383 | Purification, characterization and anticancer activities of exopolysaccharide produced by Rhodococcus erythropolis HX-2. | Int J Biol Macromol | 2020 | https://conductscience.org/library/papers/31887383 | PubMed |
| 2 | 31,067,487 | Statistical optimization, physio-chemical and bio-functional attributes of a novel exopolysaccharide from probiotic Streptomyces griseorubens GD5. | Int J Biol Macromol | 2019 | https://conductscience.org/library/papers/31067487 | PubMed |
| 3 | 32,015,464 | Discovery of "heat shock metabolites" produced by thermotolerant actinomycetes in high-temperature culture. | J Antibiot (Tokyo) | 2020 | https://conductscience.org/library/papers/32015464 | PubMed |
| 4 | 31,887,877 | Isolation, structural elucidation and immuno-stimulatory properties of polysaccharides from Cuminum cyminum. | Carbohydr Polym | 2020 | https://conductscience.org/library/papers/31887877 | PubMed |
| 5 | 17,316,584 | Structural analysis of mucoidan, an acidic extracellular polysaccharide produced by a pristane-assimilating marine bacterium, Rhodococcus erythropolis PR4. | Carbohydr Res | 2007 | https://conductscience.org/library/papers/17316584 | PubMed |
| 6 | 39,029,838 | Unlocking the therapeutic potential of bioactive exopolysaccharide produced by marine actinobacterium Streptomyces vinaceusdrappus AMG31: A novel approach to drug development. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/39029838 | PubMed |
| 7 | 37,400,624 | Characterization of biologically active exopolysaccharide produced by Streptomyces sp. NRCG4 and its anti-Alzheimer efficacy: in-vitro targets. | J Genet Eng Biotechnol | 2023 | https://conductscience.org/library/papers/37400624 | PubMed |
| 8 | 30,112,373 | Optimization of the Cytotoxic Activity of Three Streptomyces Strains Isolated from Guaviare River Sediments (Colombia, South America). | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30112373 | PubMed |
| 9 | 17,338,270 | Bioactive compounds from Streptomyces nasri and its mutants with special reference to proteopolysaccharides. | Pol J Microbiol | 2006 | https://conductscience.org/library/papers/17338270 | PubMed |
| 10 | 34,644,673 | Extracellular Polymeric Substances (EPS) produced by Streptomyces sp. biofilms: Chemical composition and anticancer properties. | Microbiol Res | 2021 | https://conductscience.org/library/papers/34644673 | PubMed |
| 11 | 36,335,804 | Streptomyces genus as a source of probiotics and its potential for its use in health. | Microbiol Res | 2023 | https://conductscience.org/library/papers/36335804 | PubMed |
| 12 | 30,629,996 | Purification, antitumor and anti-inflammation activities of an alkali-soluble and carboxymethyl polysaccharide CMP33 from Poria cocos. | Int J Biol Macromol | 2019 | https://conductscience.org/library/papers/30629996 | PubMed |
| 13 | 16,442,512 | Structural analysis of an extracellular polysaccharide produced by a benzene tolerant bacterium, Rhodococcus sp. 33. | Carbohydr Res | 2006 | https://conductscience.org/library/papers/16442512 | PubMed |
| 14 | 35,760,256 | Isolation, structure and bioactivity of polysaccharides from Atractylodes macrocephala: A review. | J Ethnopharmacol | 2022 | https://conductscience.org/library/papers/35760256 | PubMed |
| 15 | 29,254,032 | Characterization, antimicrobial and antioxidant property of exopolysaccharide mediated silver nanoparticles synthesized by Streptomyces violaceus MM72. | Carbohydr Polym | 2018 | https://conductscience.org/library/papers/29254032 | PubMed |
| 16 | 4,851,986 | Extracellular polysaccharides of Actinomyces viscosus. | Infect Immun | 1974 | https://conductscience.org/library/papers/4851986 | PubMed |
| 17 | 30,647,700 | Production and characterisation of exopolysaccharide from Streptomyces carpaticus isolated from marine sediments in Egypt and its effect on breast and colon cell lines. | J Genet Eng Biotechnol | 2018 | https://conductscience.org/library/papers/30647700 | PubMed |
| 18 | 36,757,520 | Study of exopolysaccharide produced by Streptomyces rochie strain OF1 and its effect as ameliorative on osteoarthritis in rats via inhibiting TNF-α/COX2 pathway. | J Genet Eng Biotechnol | 2023 | https://conductscience.org/library/papers/36757520 | PubMed |
| 19 | 35,255,829 | A DasA family sugar binding protein Ste2 links nutrient and oxidative stress to exopolysaccharides production in Streptomyces sp. 139. | BMC Microbiol | 2022 | https://conductscience.org/library/papers/35255829 | PubMed |
| 20 | 35,340,587 | Ebosin Attenuates the Inflammatory Responses Induced by TNF-α through Inhibiting NF-κB and MAPK Pathways in Rat Fibroblast-Like Synoviocytes. | J Immunol Res | 2022 | https://conductscience.org/library/papers/35340587 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,795,564 | Physicochemical and Functional Characterization of a Novel Extremophilic Exopolysaccharide Produced by Janibacter limosus. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795564 | PubMed |
| 41,516,370 | Extracellular Polymeric Substances Produced by Actinomycetes of the Genus Rhodococcus for Biomedical and Environmental Applications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41516370 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39690296
GET https://conductscience.org/api/papers/v1/39690296/references?page=2